NIH-funded research R01 grant

How AIM2 affects intestinal stem cell development during inflammation

Official title: Impact of AIM2 on Intestinal Stem Cell Differentiation During Inflammation

Funded at University of Arizona · NIH-11019657 · Data updated 2026-11-12

This study is looking at how a gene called AIM2 helps gut stem cells develop, especially when there’s inflammation, to better understand how gut bacteria and immune cells work together, which could lead to new ways to manage conditions like inflammatory bowel disease (IBD).

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2028
Funding year2025
Award (this year)$567,205
NIH project number1R01DK141491-01
Project IDNIH-11019657 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with inflammatory bowel diseases such as Crohn's disease or ulcerative colitis.

Less likely to help

Patients without inflammatory bowel diseases or those with unrelated gastrointestinal conditions may not benefit from this research.

What this research studies

This research investigates the role of the AIM2 gene in the differentiation of intestinal stem cells, particularly during inflammatory conditions. It focuses on understanding how interactions between gut microbes, epithelial cells, and immune cells influence intestinal health and disease. By using animal models, the research aims to uncover the mechanisms by which AIM2 contributes to the regulation of inflammation in the gut, which is crucial for conditions like inflammatory bowel disease (IBD). The findings could lead to new insights into how to better manage or treat chronic inflammatory diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from inflammatory bowel diseases.

How similar studies have gone: Previous research has shown that targeting similar pathways in animal models can lead to significant advancements in understanding and treating inflammatory bowel diseases.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Wilson, Justin Ethan — University of Arizona
  • Study coordinator: Wilson, Justin Ethan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.